查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463763

研究抗體和試劑的全球市場:市場規模和佔有率分析、工業需求預測（截至2030年）

Research Antibodies and Reagents Market Size and Share Report by Product, Type, Vertical, Source, Form, Technology, Application, End User - Global Industry Demand Forecast to 2030
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 330 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

主要亮點

全球研究抗體和試劑市場預計2023年將達到120億美元，到2030年將達到187億美元，複合年增長率為6.7%。

對臨床診斷、帶因者篩檢和新藥不斷增長的需求，以及遺傳疾病數量的快速增加，正在推動產業成長。

重要見解

到2023年，試劑類別將佔據最大佔有率，約為60%，預計這一趨勢將在未來10年持續下去。

預計到2023年，一抗將以約70%的佔有率引領業界，並持續領先業界。

到2023年，腫瘤領域將佔據最大市場佔有率，約為35%，隨著主要地區癌症發生率的上升，預計未來10年仍將保持最大市場佔有率。

到 2023 年，北美將以約 55% 的佔有率引領產業，並且由於生物技術和製藥領域的高研發活動，預計未來幾年將呈現強勁成長。

亞太地區預計將以本十年最快的速度發展。這是由於該地區國內外醫療和生物技術公司的資金增加所致。

本報告分析了全球研究用抗體和試劑市場，並提供了市場的基本結構、最新情況、主要促進和抑制因素以及全球、依地區和主要國家市場規模的前景等資訊（從貨幣角度來看，（ 2017-2030），依產品、類型、行業、原材料、形狀、技術、應用、最終用戶、當前市場競爭狀況、主要公司概況等劃分的詳細趨勢。

目錄

第一章 調查範圍

第二章 研究方法

第三章執行摘要

第四章 市場指標

第五章 產業展望

  • 市場動態
    • 趨勢
    • 促進因素
    • 抑制因素/課題
    • 促進/抑制因素影響分析
  • 新型冠狀病毒感染（COVID-19）的影響
  • 波特五力分析

第六章 世界市場

  • 概述
  • 市場收入：依產品分類（2017-2030）
    • 試劑市場收入：依類型分類（2017-2030）
  • 市場收入：依類型分類（2017-2030）
  • 市場收入：依行業分類（2017-2030）
  • 市場收入：依原料分類（2017-2030）
  • 市場收入：依形狀分類（2017-2030）
  • 市場收入：依技術分類（2017-2030）
  • 市場收入：依應用分類（2017-2030）
  • 市場收入：依最終用戶分類（2017-2030）
  • 市場收入：依地區（2017-2030）

第七章 北美市場

  • 概述
  • 市場收入：依產品分類（2017-2030）
    • 試劑市場收入：依類型分類（2017-2030）
  • 市場收入：依類型分類（2017-2030）
  • 市場收入：依行業分類（2017-2030）
  • 市場收入：依原料分類（2017-2030）
  • 市場收入：依形狀分類（2017-2030）
  • 市場收入：依技術分類（2017-2030）
  • 市場收入：依應用分類（2017-2030）
  • 市場收入：依最終用戶分類（2017-2030）
  • 市場收入：依國家分類（2017-2030）

第八章歐洲市場

第九章亞太市場

第十章 拉丁美洲市場

第十一章 中東/非洲市場

第十二章 美國市場

  • 概述
  • 市場收入：依產品分類（2017-2030）
    • 試劑市場收入：依類型分類（2017-2030）
  • 市場收入：依類型分類（2017-2030）
  • 市場收入：依行業分類（2017-2030）
  • 市場收入：依原料分類（2017-2030）
  • 市場收入：依形狀分類（2017-2030）
  • 市場收入：依技術分類（2017-2030）
  • 市場收入：依應用分類（2017-2030）
  • 市場收入：依最終用戶分類（2017-2030）

第十三章 加拿大市場

第十四章 德國市場

第十五章 法國市場

第十六章 英國市場

第十七章 義大利市場

第十八章 西班牙市場

第十九章 日本市場

第20章 中國市場

第21章 印度市場

第22章澳洲市場

第23章 韓國市場

第24章 巴西市場

第25章 墨西哥市場

第26章 沙烏地阿拉伯市場

第27章南非市場

第28章 阿拉伯聯合大公國（UAE）市場

第29章競爭格局

  • 市場參與者及其提供的產品/服務的列表
  • 主要企業競爭基準
  • 主要公司的產品基準
  • 近期策略發展狀況

第三十章 公司簡介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Abcam plc
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Teva Pharmaceutical Industries Limited
  • Eli Lilly and Company
  • Agilent Technologies Inc.

第31章附錄

簡介目錄
Product Code: 12851

Key Highlights

The research antibodies & reagents market generated USD 12.0 billion in 2023, and it will touch USD 18.7 billion, with a 6.7% CAGR, by 2030.

The rising need for clinical diagnostics, carrier screening, and new drugs, along with the surging incidence of genetic disorders is aiding the industry's growth.

The swift technological improvement in pharmaceutical platforms, the substantial application of antibodies & reagents in biotechnology & pharmaceutical analyses, and growing funding and initiatives from private and government bodies for large-scale biotechnology projects resulted in the industry expansion.

The rising research activities to produce new medicines, get them into trials and have them approved boost this industry.

Governments are funding in such activities because of the increasing incidence of chronic and infectious ailments, for discovering effective treatments.

Therefore, life sciences research activities have shattered some records in terms of scientific advancements, funding, and the variety and quantity of new medicines that are accessible to patients across the globe.

The market made some ground-breaking contributions during the pandemic of COVID-19 in the form of vaccines and therapeutics, assisted by the effective application of various research antibodies & reagents.

Key Insights

The reagents category accounted for the largest share of the industry in 2023, of approximately 60%, and it will continue this trend throughout this decade.

The growing application of biotechnology and biosciences in the pharmaceutical and healthcare sectors and the increasing biotechnical and pharmaceutical research for finding more effective, new drugs are driving the reagents category.

Primary antibodies led the industry in 2023, with approximately 70% share, and it will remain leading in the coming years.

The growth in the primary antibodies is because of the extensive variety of utilities offered by these antibodies in the R&D space; and the increasing availability of primary antibodies using goats, mice, rabbits, and various other species as hosts.

The oncology category was the largest contributor to the industry in 2023, with approximately 35% share, and it will remain the largest during this decade, because of the increasing incidence of cancer in key geographies.

The mice category led the industry because of the smaller size and high reproduction rate of the antibodies & reagents produced using mouse tissue.

The western blotting category is leading the market because of the extensive accessibility and acceptance of this method in healthcare R&D.

Monoclonal antibodies led the industry, due to the rising count of cancer research projects, which require antibodies with high specificity.

Proteomics was the largest contributor in 2023, with approximately 40% share, and it will further propel at a robust rate in the coming years.

The demand for greater effectiveness when mapping drug-protein and protein-protein interactions is boosting the proteomics category.

North America led the industry in 2023, with a share of approximately 55%, and it will advance at a robust rate in the coming years, owing to the substantial biotechnology and pharmaceutical R&D activities.

APAC will propel at the fastest rate during this decade, owing to the increasing funding from both foreign and domestic healthcare and biotechnology firms in this region.

The research antibodies & reagents industry is dynamic and competitive. Competition is powered by technological improvements, the specific demands of different research areas, and product innovation.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by type
    • 1.4.3. Market size breakdown, by vertical
    • 1.4.4. Market size breakdown, by source
    • 1.4.5. Market size breakdown, by form
    • 1.4.6. Market size breakdown, by technology
    • 1.4.7. Market size breakdown, by application
    • 1.4.8. Market size breakdown, by end user
    • 1.4.9. Market size breakdown, by region
    • 1.4.10. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2017-2030)
    • 6.2.1. Reagents market revenue, by type (2017-2030)
  • 6.3. Market Revenue, by Type (2017-2030)
  • 6.4. Market Revenue, by Vertical (2017-2030)
  • 6.5. Market Revenue, by Source (2017-2030)
  • 6.6. Market Revenue, by Form (2017-2030)
  • 6.7. Market Revenue, by Technology (2017-2030)
  • 6.8. Market Revenue, by Application (2017-2030)
  • 6.9. Market Revenue, by End User (2017-2030)
  • 6.10. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2017-2030)
    • 7.2.1. Reagents market revenue, by type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Revenue, by Vertical (2017-2030)
  • 7.5. Market Revenue, by Source (2017-2030)
  • 7.6. Market Revenue, by Form (2017-2030)
  • 7.7. Market Revenue, by Technology (2017-2030)
  • 7.8. Market Revenue, by Application (2017-2030)
  • 7.9. Market Revenue, by End User (2017-2030)
  • 7.10. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2017-2030)
    • 8.2.1. Reagents market revenue, by type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Revenue, by Vertical (2017-2030)
  • 8.5. Market Revenue, by Source (2017-2030)
  • 8.6. Market Revenue, by Form (2017-2030)
  • 8.7. Market Revenue, by Technology (2017-2030)
  • 8.8. Market Revenue, by Application (2017-2030)
  • 8.9. Market Revenue, by End User (2017-2030)
  • 8.10. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2017-2030)
    • 9.2.1. Reagents market revenue, by type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Revenue, by Vertical (2017-2030)
  • 9.5. Market Revenue, by Source (2017-2030)
  • 9.6. Market Revenue, by Form (2017-2030)
  • 9.7. Market Revenue, by Technology (2017-2030)
  • 9.8. Market Revenue, by Application (2017-2030)
  • 9.9. Market Revenue, by End User (2017-2030)
  • 9.10. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2017-2030)
    • 10.2.1. Reagents market revenue, by type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Revenue, by Vertical (2017-2030)
  • 10.5. Market Revenue, by Source (2017-2030)
  • 10.6. Market Revenue, by Form (2017-2030)
  • 10.7. Market Revenue, by Technology (2017-2030)
  • 10.8. Market Revenue, by Application (2017-2030)
  • 10.9. Market Revenue, by End User (2017-2030)
  • 10.10. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2017-2030)
    • 11.2.1. Reagents market revenue, by type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Revenue, by Vertical (2017-2030)
  • 11.5. Market Revenue, by Source (2017-2030)
  • 11.6. Market Revenue, by Form (2017-2030)
  • 11.7. Market Revenue, by Technology (2017-2030)
  • 11.8. Market Revenue, by Application (2017-2030)
  • 11.9. Market Revenue, by End User (2017-2030)
  • 11.10. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2017-2030)
    • 12.2.1. Reagents market revenue, by type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Revenue, by Vertical (2017-2030)
  • 12.5. Market Revenue, by Source (2017-2030)
  • 12.6. Market Revenue, by Form (2017-2030)
  • 12.7. Market Revenue, by Technology (2017-2030)
  • 12.8. Market Revenue, by Application (2017-2030)
  • 12.9. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2017-2030)
    • 13.2.1. Reagents market revenue, by type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Revenue, by Vertical (2017-2030)
  • 13.5. Market Revenue, by Source (2017-2030)
  • 13.6. Market Revenue, by Form (2017-2030)
  • 13.7. Market Revenue, by Technology (2017-2030)
  • 13.8. Market Revenue, by Application (2017-2030)
  • 13.9. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2017-2030)
    • 14.2.1. Reagents market revenue, by type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Revenue, by Vertical (2017-2030)
  • 14.5. Market Revenue, by Source (2017-2030)
  • 14.6. Market Revenue, by Form (2017-2030)
  • 14.7. Market Revenue, by Technology (2017-2030)
  • 14.8. Market Revenue, by Application (2017-2030)
  • 14.9. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2017-2030)
    • 15.2.1. Reagents market revenue, by type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Revenue, by Vertical (2017-2030)
  • 15.5. Market Revenue, by Source (2017-2030)
  • 15.6. Market Revenue, by Form (2017-2030)
  • 15.7. Market Revenue, by Technology (2017-2030)
  • 15.8. Market Revenue, by Application (2017-2030)
  • 15.9. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2017-2030)
    • 16.2.1. Reagents market revenue, by type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Revenue, by Vertical (2017-2030)
  • 16.5. Market Revenue, by Source (2017-2030)
  • 16.6. Market Revenue, by Form (2017-2030)
  • 16.7. Market Revenue, by Technology (2017-2030)
  • 16.8. Market Revenue, by Application (2017-2030)
  • 16.9. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2017-2030)
    • 17.2.1. Reagents market revenue, by type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Revenue, by Vertical (2017-2030)
  • 17.5. Market Revenue, by Source (2017-2030)
  • 17.6. Market Revenue, by Form (2017-2030)
  • 17.7. Market Revenue, by Technology (2017-2030)
  • 17.8. Market Revenue, by Application (2017-2030)
  • 17.9. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2017-2030)
    • 18.2.1. Reagents market revenue, by type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Revenue, by Vertical (2017-2030)
  • 18.5. Market Revenue, by Source (2017-2030)
  • 18.6. Market Revenue, by Form (2017-2030)
  • 18.7. Market Revenue, by Technology (2017-2030)
  • 18.8. Market Revenue, by Application (2017-2030)
  • 18.9. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2017-2030)
    • 19.2.1. Reagents market revenue, by type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Revenue, by Vertical (2017-2030)
  • 19.5. Market Revenue, by Source (2017-2030)
  • 19.6. Market Revenue, by Form (2017-2030)
  • 19.7. Market Revenue, by Technology (2017-2030)
  • 19.8. Market Revenue, by Application (2017-2030)
  • 19.9. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2017-2030)
    • 20.2.1. Reagents market revenue, by type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Revenue, by Vertical (2017-2030)
  • 20.5. Market Revenue, by Source (2017-2030)
  • 20.6. Market Revenue, by Form (2017-2030)
  • 20.7. Market Revenue, by Technology (2017-2030)
  • 20.8. Market Revenue, by Application (2017-2030)
  • 20.9. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2017-2030)
    • 21.2.1. Reagents market revenue, by type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Revenue, by Vertical (2017-2030)
  • 21.5. Market Revenue, by Source (2017-2030)
  • 21.6. Market Revenue, by Form (2017-2030)
  • 21.7. Market Revenue, by Technology (2017-2030)
  • 21.8. Market Revenue, by Application (2017-2030)
  • 21.9. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2017-2030)
    • 22.2.1. Reagents market revenue, by type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Revenue, by Vertical (2017-2030)
  • 22.5. Market Revenue, by Source (2017-2030)
  • 22.6. Market Revenue, by Form (2017-2030)
  • 22.7. Market Revenue, by Technology (2017-2030)
  • 22.8. Market Revenue, by Application (2017-2030)
  • 22.9. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2017-2030)
    • 23.2.1. Reagents market revenue, by type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Revenue, by Vertical (2017-2030)
  • 23.5. Market Revenue, by Source (2017-2030)
  • 23.6. Market Revenue, by Form (2017-2030)
  • 23.7. Market Revenue, by Technology (2017-2030)
  • 23.8. Market Revenue, by Application (2017-2030)
  • 23.9. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2017-2030)
    • 24.2.1. Reagents market revenue, by type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Revenue, by Vertical (2017-2030)
  • 24.5. Market Revenue, by Source (2017-2030)
  • 24.6. Market Revenue, by Form (2017-2030)
  • 24.7. Market Revenue, by Technology (2017-2030)
  • 24.8. Market Revenue, by Application (2017-2030)
  • 24.9. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2017-2030)
    • 25.2.1. Reagents market revenue, by type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Revenue, by Vertical (2017-2030)
  • 25.5. Market Revenue, by Source (2017-2030)
  • 25.6. Market Revenue, by Form (2017-2030)
  • 25.7. Market Revenue, by Technology (2017-2030)
  • 25.8. Market Revenue, by Application (2017-2030)
  • 25.9. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2017-2030)
    • 26.2.1. Reagents market revenue, by type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Revenue, by Vertical (2017-2030)
  • 26.5. Market Revenue, by Source (2017-2030)
  • 26.6. Market Revenue, by Form (2017-2030)
  • 26.7. Market Revenue, by Technology (2017-2030)
  • 26.8. Market Revenue, by Application (2017-2030)
  • 26.9. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2017-2030)
    • 27.2.1. Reagents market revenue, by type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Revenue, by Vertical (2017-2030)
  • 27.5. Market Revenue, by Source (2017-2030)
  • 27.6. Market Revenue, by Form (2017-2030)
  • 27.7. Market Revenue, by Technology (2017-2030)
  • 27.8. Market Revenue, by Application (2017-2030)
  • 27.9. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2017-2030)
    • 28.2.1. Reagents market revenue, by type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Revenue, by Vertical (2017-2030)
  • 28.5. Market Revenue, by Source (2017-2030)
  • 28.6. Market Revenue, by Form (2017-2030)
  • 28.7. Market Revenue, by Technology (2017-2030)
  • 28.8. Market Revenue, by Application (2017-2030)
  • 28.9. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Thermo Fisher Scientific Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Merck KGaA
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Abcam plc
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Becton, Dickinson and Company
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. F. Hoffmann-La Roche Ltd.
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. PerkinElmer Inc.
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Bio-Rad Laboratories Inc.
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Teva Pharmaceutical Industries Limited
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Eli Lilly and Company
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Agilent Technologies Inc.
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports